| Outgoing Relation(s) |
| G-protein-coupled receptor antagonist (CHEBI:88295) is a antagonist (CHEBI:48706) |
| Incoming Relation(s) |
| [(3S,4R,8R,9E)-10-methyl-5-methylidene-6,14-dioxo-7,13-dioxatricyclo[10.2.1.04,8]pentadeca-1(15),9-dien-3-yl] (Z)-2-methylbut-2-enoate (CHEBI:232588) has role G-protein-coupled receptor antagonist (CHEBI:88295) |
| DFL23916 (CHEBI:235317) has role G-protein-coupled receptor antagonist (CHEBI:88295) |
| G-15 (CHEBI:156295) has role G-protein-coupled receptor antagonist (CHEBI:88295) |
| gallein (CHEBI:88294) has role G-protein-coupled receptor antagonist (CHEBI:88295) |
| C3a receptor antagonist (CHEBI:228139) is a G-protein-coupled receptor antagonist (CHEBI:88295) |
| C5a receptor antagonist (CHEBI:144895) is a G-protein-coupled receptor antagonist (CHEBI:88295) |
| calcitonin gene-related peptide receptor antagonist (CHEBI:196956) is a G-protein-coupled receptor antagonist (CHEBI:88295) |
| P2Y14 receptor antagonist (CHEBI:233336) is a G-protein-coupled receptor antagonist (CHEBI:88295) |
| protease-activated receptor-1 antagonist (CHEBI:83313) is a G-protein-coupled receptor antagonist (CHEBI:88295) |
| protease-activated receptor-2 antagonist (CHEBI:189676) is a G-protein-coupled receptor antagonist (CHEBI:88295) |
